Cargando…
Coronavirus (COVID-19) in Nigeria: Survival rate
The novel coronavirus is a new disease threatening the population size and economic activities across the world. Due to the poverty rate in Africa, as well as poor access to quality health care, inadequate medical staff and poor technology, Africa has been predicted to be one of the most severely af...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772582/ https://www.ncbi.nlm.nih.gov/pubmed/33392422 http://dx.doi.org/10.1016/j.sciaf.2020.e00689 |
_version_ | 1783629903282831360 |
---|---|
author | Aronu, Charles Okechukwu Ekwueme, Godspower Onyekachukwu Sol-Akubude, Vincent Ikemefuna Okafor, Patrick Nnaemeka |
author_facet | Aronu, Charles Okechukwu Ekwueme, Godspower Onyekachukwu Sol-Akubude, Vincent Ikemefuna Okafor, Patrick Nnaemeka |
author_sort | Aronu, Charles Okechukwu |
collection | PubMed |
description | The novel coronavirus is a new disease threatening the population size and economic activities across the world. Due to the poverty rate in Africa, as well as poor access to quality health care, inadequate medical staff and poor technology, Africa has been predicted to be one of the most severely affected continents in the world by COVID-19. The objective of this study was to examine the survival rate of COVID-19 patients in Nigeria using the Autoregressive Integrated Moving Average (ARIMA) forecasting approach. The source of the data used for this study was the secondary data obtained from the daily publication/report of the Nigeria Centre for Disease Control (NCDC) from 28th February 2020 to 30th June 2020. The mean daily survival rate of COVID-19 patients was found to be 27.5% with a median survival rate of 25.4% which is below 50%. Also, the ARIMA (0, 1, 1) was identified to be appropriate for predicting the survival rate of COVID-19 patients in Nigeria within the observed period. Further findings showed that little variation exists between the predicted and actual survival rate of COVID19 for June 2020 which indicates that the obtained ARIMA model (0, 1, 1) was adequate for the estimation of the survival rate of COVID-19 in Nigeria. Based on the findings of the study, the need for the Nigerian government to explore effective treatment strategies both internationally and locally to improve the survival rate of patients with the disease was strongly recommended. Also, the need for the government to encourage local manufacturing of Personal Protective Equipment (PPE) such as garment, which is expected to help health workers effectively manage affected persons without being infected at the front line was recommended. |
format | Online Article Text |
id | pubmed-7772582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77725822020-12-30 Coronavirus (COVID-19) in Nigeria: Survival rate Aronu, Charles Okechukwu Ekwueme, Godspower Onyekachukwu Sol-Akubude, Vincent Ikemefuna Okafor, Patrick Nnaemeka Sci Afr Article The novel coronavirus is a new disease threatening the population size and economic activities across the world. Due to the poverty rate in Africa, as well as poor access to quality health care, inadequate medical staff and poor technology, Africa has been predicted to be one of the most severely affected continents in the world by COVID-19. The objective of this study was to examine the survival rate of COVID-19 patients in Nigeria using the Autoregressive Integrated Moving Average (ARIMA) forecasting approach. The source of the data used for this study was the secondary data obtained from the daily publication/report of the Nigeria Centre for Disease Control (NCDC) from 28th February 2020 to 30th June 2020. The mean daily survival rate of COVID-19 patients was found to be 27.5% with a median survival rate of 25.4% which is below 50%. Also, the ARIMA (0, 1, 1) was identified to be appropriate for predicting the survival rate of COVID-19 patients in Nigeria within the observed period. Further findings showed that little variation exists between the predicted and actual survival rate of COVID19 for June 2020 which indicates that the obtained ARIMA model (0, 1, 1) was adequate for the estimation of the survival rate of COVID-19 in Nigeria. Based on the findings of the study, the need for the Nigerian government to explore effective treatment strategies both internationally and locally to improve the survival rate of patients with the disease was strongly recommended. Also, the need for the government to encourage local manufacturing of Personal Protective Equipment (PPE) such as garment, which is expected to help health workers effectively manage affected persons without being infected at the front line was recommended. The Author(s). Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative. 2021-03 2020-12-30 /pmc/articles/PMC7772582/ /pubmed/33392422 http://dx.doi.org/10.1016/j.sciaf.2020.e00689 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Aronu, Charles Okechukwu Ekwueme, Godspower Onyekachukwu Sol-Akubude, Vincent Ikemefuna Okafor, Patrick Nnaemeka Coronavirus (COVID-19) in Nigeria: Survival rate |
title | Coronavirus (COVID-19) in Nigeria: Survival rate |
title_full | Coronavirus (COVID-19) in Nigeria: Survival rate |
title_fullStr | Coronavirus (COVID-19) in Nigeria: Survival rate |
title_full_unstemmed | Coronavirus (COVID-19) in Nigeria: Survival rate |
title_short | Coronavirus (COVID-19) in Nigeria: Survival rate |
title_sort | coronavirus (covid-19) in nigeria: survival rate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772582/ https://www.ncbi.nlm.nih.gov/pubmed/33392422 http://dx.doi.org/10.1016/j.sciaf.2020.e00689 |
work_keys_str_mv | AT aronucharlesokechukwu coronaviruscovid19innigeriasurvivalrate AT ekwuemegodspoweronyekachukwu coronaviruscovid19innigeriasurvivalrate AT solakubudevincentikemefuna coronaviruscovid19innigeriasurvivalrate AT okaforpatricknnaemeka coronaviruscovid19innigeriasurvivalrate |